Revance Therapeutics, Inc.
Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds

Abstract:

Methods of using botulinum toxin based pharmaceuticals are disclosed. The methods cause vasodilatation and decreased flow resistance of certain vascular beds for the purpose of increasing blood flow to a region in order to positively impact deterioration from a number of diseases.